Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Agensys

Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and validated a rich portfolio of novel, clinically relevant cancer targets to 14 different cancer types that have been carefully selected to enable development of new effective therapeutics with fewer and less severe side effects. All of Agensys' cancer targets must meet the following criteria: (1) a novel molecule and/or a novel utility in cancer; (2) expression in a significant percentage of patients' specimens; (3) limited expression in normal vital tissues; and (4) structural and functional features suitable for therapeutic intervention. The Company is generating fully human antibodies to multiple targets from its portfolio, including those directed to prostate, kidney, bladder, colon, lung, ovary and pancreatic cancers. The Company's portfolio also contains multiple validated targets for small molecule and vaccine products that it intends to develop through partnerships with pharmaceutical and biotechnology companies.


Contact Details:
1545 17th Street
Santa Monica
California
90404
United States of America
Tel:(310) 820-8029
Fax:(310) 820-8489
Email:info@agensys.com
WWW:

www.agensys.com/




Loading...

Recent Publications by Agensys:

Monoclonal antibody therapy for prostate cancer.
Early detection of prostate cancer (PCa) and advances in hormonal and...
9th January, 2008
Agensys Inc., 1545 17th Street, Santa Monica, CA 90404, USA. Handb Exp Pharmacol. 2008;(181):237-56.
DOI Direct Link
From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice.
Therapeutic monoclonal antibodies have shown limited efficacy and safety...
9th January, 2008
Agensys, Inc., 2225 Colorado Blvd., Santa Monica, California 90404, USA. Nat Biotechnol. 2007 Oct;25(10):1134-43.
DOI Direct Link
Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.
Six-transmembrane epithelial antigen of the prostate-1 (STEAP-1) is a...
26th September, 2007
Agensys, Inc., Santa Cancer Res. 2007 Jun 15;67(12):5798-805.
DOI Direct Link

Press Releases on Agensys:

BioPortfolio Logo
US HIFU Appoints Arie Belldegrun, M.D. to Board of Directors 5th October, 2009 US HIFU, LLC
CHARLOTTE, N.C., Oct. 5 /PRNewswire/ -- US HIFU, LLC, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, announced
Nile Therapeutics Appoints Arie S. Belldegrun, M.D., to Board of Directors 29th September, 2009 Nile Therapeutics, Inc.
SAN FRANCISCO, Sept. 29 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced the

BioNews Results for Agensys:

Nile Therapeutics Appoints Arie S. Belldegrun, M.D., to Board of Directors
Pharma Live:  Sep 29 2009 1:02PM Matching: agensys

Agensys Clinical Trials:

AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

Agensys Patents:

US Patent No.Title
7135549 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
7271240 125P5C8: a tissue specific protein highly expressed in various cancers
7279556 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
7306796 13-transmembrane protein expressed in prostate cancer
7309585 121P1F1: a tissue specific protein highly expressed in various cancers

View more Agensys patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 521 times since April 2007, the link to the organisation's website has been followed 80 times

Recent Search Terms used to find this page: monoclonal antibodies ags 1c4d4 | agensys | HIFU press releases | Steap 1 mabs agensys | Agensys, Inc | Agensys | agensys 1545 17th Street Santa Monica CA 90404 | agensys | .

Search for more companies in Santa Monica

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Agensys

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.